Du L, Yau C, Brown-Swigart L, Gould R, et al. Predicted sensitivity to endocrine therapy for stage II-III hormone
receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to
chemo-endocrine therapy. Ann Oncol 2021 Feb 19. pii: S0923-7534(21)00128.
PMID: 33617937